Discovery of a Good Responder Subtype of Esophageal Squamous Cell Carcinoma with Cytotoxic T-Lymphocyte Signatures Activated by Chemoradiotherapy-Reference-Cited by-同舟云学术

Discovery of a Good Responder Subtype of Esophageal Squamous Cell Carcinoma with Cytotoxic T-Lymphocyte Signatures Activated by Chemoradiotherapy

Published:2015-12-01 Issue:12 Volume:10 Page:e0143804
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Tanaka Yosuke,Aoyagi Kazuhiko,Minashi Keiko,Komatsuzaki Rie,Komatsu Masayuki,Chiwaki Fumiko,Tamaoki Masashi,Nishimura Takao,Takahashi Naoki,Oda Ichiro,Tachimori Yuji,Arao Tokuzo,Nishio Kazuto,Kitano Shigehisa,Narumi Kenta,Aoki Kazunori,Fujii Satoshi,Ochiai Atsushi,Yoshida Teruhiko,Muto Manabu,Yamada Yasuhide,Sasaki Hiroki

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference28 articles.

1. Surgery for cancer of the esophagus;JA Roth;Semin Oncol,1994

2. Radical lymph node dissection for cancer of the thoracic esophagus;H Akiyama;Ann Surg,1994

3. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis;V Gebski;The Lancet Oncology,2007

4. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907);N Ando;Ann Surg Oncol,2012

5. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus;A Ohtsu;J Clin Oncol,1999

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perforin 1 in Cancer: Mechanisms, Therapy, and Outlook;Biomolecules;2024-07-26

2. Neoadjuvant Chemoradiotherapy Upregulates the Immunogenicity of Cold to Hot Tumors in Esophageal Cancer Patients;Annals of Surgery Open;2024-02-02

3. A novel CT-based radiomics model for predicting response and prognosis of chemoradiotherapy in esophageal squamous cell carcinoma;Scientific Reports;2024-01-23

4. Stratification From Heterogeneity of the Cell-Death Signal Enables Prognosis Prediction and Immune Microenvironment Characterization in Esophageal Squamous Cell Carcinoma;Frontiers in Cell and Developmental Biology;2022-04-12

5. MEOX2 serves as a novel biomarker associated with macrophage infiltration in oesophageal squamous cell carcinoma and other digestive system carcinomas;Autoimmunity;2021-06-23